Pregnenolone monosulfate是包括甾体酮在内的各种甾体激素的主要前体，具有多种生物学功能。
Cas No.:1247-64-9
Sample solution is provided at 25 µL, 10mM.
_1-3.$$$39978408@51.jpg');)
_1-9.$$$38538795@65.jpg');)
_1-9.$$$39112701@51.jpg');)
_1-7.$$$37316672@70.jpg');)
_366-372.$$$36198801@70.jpg');)
.$$$38565142@65.jpg');)
_1867-1883.$$$33248023@67.jpg');)
_eads6055.$$$39977546@45.jpg');)
_eadm9805.$$$40080571@45.jpg');)
_eadj3020.$$$39666821@45.jpg');)
_1-20.$$$39757301@28.jpg');)
_1-24.$$$38898113@28.jpg');)
_273-287.$$$36806353@46.jpg');)
_1-16.$$$37156877@44.jpg');)
_1-19.$$$37460805@44.jpg');)
_1291-1307.$$$34518654@46.jpg');)
Pregnenolone monosulfate is a key precursor to various steroid hormones, including steroid hormones, and possesses multiple biological functions[1-2]. Pregnenolone monosulfate can be utilized in neuroscience research and related nervous system disorders[3-4].
In vitro, Pregnenolone monosulfate (5-300μM) was applied to GH3 pituitary cells for 1 minute, Pregnenolone monosulfate induced a rapid and transient increase in intracellular calcium ion ([Ca²⁺]i) levels. Pregnenolone monosulfate activated L-type voltage-gated calcium channels, mediating extracellular calcium influx[5]. In neonatal rat cerebellar Purkinje cells (P4–10), Pregnenolone monosulfate (25μM) enhanced glutamate release by promoting presynaptic calcium influx through transient receptor potential (TRP) channels, Pregnenolone monosulfate significantly increased AMPA receptor-mediated miniature excitatory postsynaptic currents (AMPA-mEPSCs)[6].
In vivo, in dopamine transporter knockout (DAT-KO) mice (8-10 weeks old), Pregnenolone monosulfate (40 or 80mg/kg; administered either as a single injection or daily for 10 consecutive days via intraperitoneal injection). Pregnenolone monosulfate significantly suppressed hyperlocomotion and stereotypic behaviors, rescued prepulse inhibition deficits, and improved cognitive impairments in novel object recognition and social food preference tests. The therapeutic effects of Pregnenolone monosulfate were mediated through the AKT/GSK3β pathway and increased expression of the hippocampal NMDA receptor NR1 subunit[7]. In wild-type mice (9-10 weeks old), a single subcutaneous injection of Pregnenolone monosulfate (6mg/kg), Pregnenolone monosulfate antagonized Δ9-tetrahydrocannabinol (THC)-induced psychotic-like behaviors, significantly blocked THC-induced cognitive impairments, sensory gating deficits, and reduced social interaction[8].
References:
[1] Vallée M, Vitiello S, Bellocchio L, et al. Pregnenolone can protect the brain from cannabis intoxication. Science. 2014 Jan 3;343(6166):94-8.
[2] Ducharme N, Banks WA, Morley JE, et al. Brain distribution and behavioral effects of progesterone and pregnenolone after intranasal or intravenous administration. Eur J Pharmacol. 2010 Sep 1;641(2-3):128-34.
[3] Shiels A. TRPM3_miR-204: a complex locus for eye development and disease. Hum Genomics. 2020 Feb 18;14(1):7.
[4] Weaver CE Jr, Wu FS, Gibbs TT, et al. Pregnenolone sulfate exacerbates NMDA-induced death of hippocampal neurons. Brain Res. 1998 Aug 24;803(1-2):129-36.
[5] Büküşoğlu C, Sarlak F. Pregnenolone sulfate increases intracellular Ca2+ levels in a pituitary cell line. Eur J Pharmacol. 1996 Feb 29;298(1):79-85.
[6] Zamudio-Bulcock PA, Valenzuela CF. Pregnenolone sulfate increases glutamate release at neonatal climbing fiber-to-Purkinje cell synapses. Neuroscience. 2011 Feb 23;175:24-36.
[7] Wong P, Sze Y, Chang CC, et al. Pregnenolone sulfate normalizes schizophrenia-like behaviors in dopamine transporter knockout mice through the AKT/GSK3β pathway. Transl Psychiatry. 2015 Mar 17;5(3):e528.
[8] Busquets-Garcia A, Soria-Gómez E, Redon B, et al. Pregnenolone blocks cannabinoid-induced acute psychotic-like states in mice. Mol Psychiatry. 2017 Nov;22(11):1594-1603.
Pregnenolone monosulfate是包括甾体酮在内的各种甾体激素的主要前体，具有多种生物学功能[1-2]。Pregnenolone monosulfate可用于神经科学及相关神经系统疾病的研究[3-4]。
在体外，Pregnenolone monosulfate（5-300μM）处理GH3垂体细胞1分钟，可诱导快速、瞬态的细胞内钙离子（[Ca²⁺]i）水平升高，Pregnenolone monosulfate激活L型电压门控钙通道，介导细胞外钙离子内流 [5]。Pregnenolone monosulfate（25μM）处理新生大鼠小脑浦肯野细胞（P4–10），Pregnenolone monosulfate通过瞬时受体电位（TRP）通道介导的突触前钙内流增强谷氨酸释放，显著增加AMPA受体介导的微小兴奋性突触后电流（AMPA-mEPSC）[6]。
在体内，Pregnenolone monosulfate（40或80mg/kg；单次或连续10天腹腔注射）处理多巴胺转运体敲除（DAT-KO）小鼠（8-10周龄），Pregnenolone monosulfate显著抑制小鼠的高活动性和刻板行为，挽救前脉冲抑制缺陷，并改善新物体识别和社会性食物偏好测试中的认知缺陷，Pregnenolone monosulfate通过AKT/GSK3β通路和增加海马NMDA受体NR1亚基表达水平发挥治疗作用[7]。Pregnenolone monosulfate（6mg/kg；单次皮下注射）处理野生型小鼠（9-10周龄），Pregnenolone monosulfate可拮抗Δ9-四氢大麻酚（THC）诱导的精神病样行为，Pregnenolone monosulfate显著阻断THC引起的认知功能损伤、感觉门控缺陷和社会互动减少[8]。
| Cell experiment [1]: | |
Cell lines | GH3 cells (rat pituitary clonal cell line) |
Preparation Method | GH3 cells were cultured as monolayers on glass coverslips in Dulbecco’s modified Eagle medium supplemented with 10% fetal bovine serum at 37°C, 5% CO₂. Cells were loaded with Fura-2/AM (5μM) for 30 min and perfused with physiological buffer. Pregnenolone monosulfate (5–300μM) was applied via perfusion for 1min. |
Reaction Conditions | 5–300μM; 1min |
Applications | Pregnenolone monosulfate induced a rapid, dose-dependent increase in intracellular Ca²⁺ ([Ca²⁺]ᵢ) in GH3 cells, with an EC₅₀ of ~32μM. The [Ca²⁺]ᵢ surge was abolished in Ca²⁺-free medium or in the presence of inorganic Ca²⁺ channel blockers (La³⁺, Co²⁺). Organic L-type voltage-gated Ca²⁺ channel (VGCC) blockers (nicardipine, D600) inhibited the response, indicating that the Ca²⁺ influx is primarily mediated through L-type VGCCs. Co-application with the VGCC agonist Bay K 8644 potentiated the effect, suggesting synergistic modulation of Ca²⁺ channels. |
| Animal experiment [2]: | |
Animal models | C57BL/6-N mice (9–10 weeks old) |
Preparation Method | Mice were subcutaneously (s.c.) administered Pregnenolone monosulfate (6mg/kg) either 10 minutes before or 30 minutes after intraperitoneal (i.p.) injection of Δ9-tetrahydrocannabinol (THC; 0.3–10mg/kg). Behavioral tests (e.g., spontaneous alternation, social interaction, prepulse inhibition, locomotion, and "reality testing") were conducted at specified time points post-THC administration (45–120 minutes). |
Dosage form | 6mg/kg; s.c.; Acute single injection. |
Applications | Pregnenolone monosulfate blocked a wide spectrum of THC-induced psychotic-like behaviors, including cognitive deficits, reduced prepulse inhibition, decreased social interaction, hyperlocomotion, and impaired "reality testing" (a measure of mental sensory representations). |
References: | |
| Cas No. | 1247-64-9 | SDF | |
| 别名 | 3β-Hydroxy-5-pregnen-20-one monosulfate | ||
| Canonical SMILES | CC([C@H]1CC[C@@]2([H])[C@]3([H])CC=C4C[C@@H](OS(=O)(O)=O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)=O | ||
| 分子式 | C21H32O5S | 分子量 | 396.54 |
| 溶解度 | DMSO: 62.5 mg/mL (157.61 mM) | 储存条件 | Store at -20°C,stored under nitrogen |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 2.5218 mL | 12.6091 mL | 25.2181 mL |
| 5 mM | 504.4 μL | 2.5218 mL | 5.0436 mL |
| 10 mM | 252.2 μL | 1.2609 mL | 2.5218 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00% Appearance: A solid
- COA (Certificate of Analysis)
- SDS (Safety Data Sheet)
- Datasheet